ArticleBioinformation2014

Molecular docking studies shows tivozanib and lapatinib as potential inhibitors of EML4-ALK translocation mediated fusion protein in non small cell lung cancer.

Vijayalakshmi Ramshankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.